M. Antonio Araujo Da Rocha Loures

POS0084 SAFETY OF TARGETED THERAPIES IN IMMUNE MEDIATED INFLAMMATORY DISEASES: COMBINED DATA FROM FIVE COUNTRIES OF LATIN AMERICA

P. DE Abreu Trigueros, D. Alpizar-Rodriguez, V. Rivera Terán, Iêda Maria Magalhães Laurindo et autres

py, ar (code pays fourni par la source)

POS0916 DRUG SURVIVAL OF BIOLOGIC AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIS: DATA FROM FIVE COUNTRIES OF LATIN AMERICA

D. Alpizar-Rodriguez, C. A. Isnardi, V. Rivera Terán, I. Laurindo et autres

ar, py (code pays fourni par la source)

POS0640 ANTIMALARIALS AND THE RISK OF OCULAR ADVERSE EVENTS IN RHEUMATOID ARTHRITIS: LOOKING BEYOND THE RARE OccURRENCE OF DRUG INDUCED RETINOPATHY

Markus Bredemeier, Suelem Estefano Ramos, C. Solórzano, Carolina Vieira Tavares et autres

br (code pays fourni par la source)

AB0508 THE EFFECT OF COMBINATIONS OF CONVENTIONAL SYNTHETIC DMARDs ON THE SAFETY AND TREATMENT RETENTION OF BIOLOGIC AGENTS OR JAK INHIBITORS IN RHEUMATOID ARTHRITIS

M. Bredemeier, C. Solórzano, Carolina Vieira Tavares, A. M. Baier et autres

COMPARING THE SAFETY OF ADALIMUMAB AND ETANERCEPT AS FIRST BIOLOGIC IN RHEUMATOID ARTHRITIS: SIMULATING A RANDOMIZED CONTROLLED TRIAL USING DATA FROM BIOBADABRASIL COHORT

Markus Bredemeier, M. Silvestri Pauwelz, E. Reginatto, Ângela Luzia Branco Pinto Duarte et autres

br (code pays fourni par la source)

ANTIMALARIALS AND THE RISK OF OCULAR ADVERSE EVENTS IN RHEUMATOID ARTHRITIS: LOOKING BEYOND THE RARE OCCURRENCE OF DRUG INDUCED RETINOPATHY

Markus Bredmeier, Suelem Estefano Ramos, C. Solórzano, Carolina Vieira Tavares et autres

br (code pays fourni par la source)

OP0223 THE EFFECT OF ANTIMALARIALS ON THE RISK AND SEVERITY OF BACTERIAL, VIRAL, FUNGAL AND SYSTEMIC-SPECIFIC INFECTIONS IN RHEUMATOID ARTHRITIS

Markus Bredemeier, Moniki de Oliveira Barbosa Campos, Felipe Cargnelutti Possamai Della, A. Duarte et autres

br (code pays fourni par la source)

AB0428 SAFETY AND PERSISTENCE OF TREATMENT WITH GOLIMUMAB VERSUS CERTOLIZUMAB IN RHEUMATOID ARTHRITIS: RESULTS FROM BIOBADABRASIL COHORT STUDY.

Markus Bredemeier, C. Solórzano, Alessandra Fernandes Duarte, Marcilene da Silva Pinheiro et autres

br (code pays fourni par la source)

PREVALENCE AND ASSOCIATIONS OF HLA-B27 IN A LARGE MULTIRACIAL COHORT OF THE BRAZILIAN REGISTRY OF SPONDYLOARTHRITIS

Gustavo Gomes Rresende, Carla Gonçalves Schahin Saad, Cláudia Diniz Lopes Marques, Sandra Lúcia Euzébio Ribeiro et autres

br (code pays fourni par la source)

THE EFFECT OF ANTIMALARIALS ON THE RISK AND SEVERITY OF BACTERIAL, VIRAL, FUNGAL AND SYSTEMIC SPECIFIC INFECTIONS IN RHEUMATOID ARTHRITIS

Markus Bredemeier, Mônica Rodrigues Campos, Felipe Cargnelutti Possamai Della, Ângela Luzia Branco Pinto Duarte et autres

br (code pays fourni par la source)

SAFETY AND PERSISTENCE OF TREATMENT WITH GOLIMUMAB VERSUS CERTOLIZUMAB IN RHEUMATOID ARTHRITIS: RESULTS FROM A COHORT STUDY

Markus Bredemeier, Suelem Ramos, Camila Solórzano, Ângela Luzia Branco Pinto Duarte et autres

br, uy (code pays fourni par la source)